Name: Who owns enGene Therapeutics Inc.? Owners, funding and legal record
Creator: MentionFox

Before you sign or pay

Court and bankruptcy: No federal court case or bankruptcy filing found under enGene Holdings Inc. in our court records and SEC 8-K records (as of 2026-10-18).
Layoffs: 2 exit or restructuring plans reported on Form 8-K, Item 2.05 (latest filed 2026-06-18).
Leadership changes: the latest reported is Richard Glickman, Director (Form 8-K filed 2026-07-16). Check you are dealing with the people now in charge.
Ownership: 5%+ holders are reported on Schedule 13D or 13G; the latest names Perceptive Advisors LLC (filed 2026-08-14).

Who is behind it

enGene Therapeutics Inc.: industry Biological Products, (No Diagnostic Substances) (Schedule 13G/A, 2026-08-14).

Report	Holder	Share
Schedule 13G/A, 2026-08-14	Perceptive Advisors LLC	9.99%
Schedule 13G/A, 2026-08-14	Deep Track Capital, LP	0%
Schedule 13G/A, 2026-08-14	Venrock Healthcare Capital Partners Iii, L.P.	0%
Schedule 13G/A, 2026-08-13	Raymond Debbane	9.3%
Schedule 13G/A, 2026-08-12	Blue Owl Capital Holdings LP	0.76%
Schedule 13G, 2026-07-22	Anders Hove	5%
Schedule 13G/A, 2026-05-15	Cormorant Asset Management, LP	0%
Schedule 13G/A, 2026-05-14	Bml Investment Partners, L.P.	9.95%

Filed	Person	Role	Change	Effective
Form 8-K, 2026-07-16	Richard Glickman	Director	departed
Form 8-K, 2026-06-15	Hussein Sweiti	Chief Medical Officer	departed	2026-06-14

No fundraising or offering filing from enGene Therapeutics Inc. is on file with us.

2 exit or restructuring plans on Form 8-K (latest Form 8-K, 2026-06-18).

Filings, cases and notices link to their records. A not-found line names the records searched; it is not proof of absence.

Not for employment, credit, insurance or tenancy decisions.

Permanent URL: https://mentionfox.com/who-owns/engene

Last updated 2026-10-18

Who owns enGene Therapeutics Inc.? Owners, funding and legal record. MentionFox, 2026-10-18. https://mentionfox.com/who-owns/engene